[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545448":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":48,"collaborators":18,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":18,"enrollmentInfo":60,"targetDuration":18,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":71,"overallStatus":72,"whyStopped":18,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Navy General Hospital, Beijing","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"mVTEA Management Group","EXPERIMENTAL","Patients randomly assigned to the mVTEA management group will be discharged with mVTEA-assisted patient-centered PTE management.",[13],"Other: mobile venous thromboembolism application (mVTEA)",{"label":15,"type":16,"description":17,"interventionNames":18},"Routine Management Group","NO_INTERVENTION","Patients randomly assigned to the routine management group will be given routine post-discharge management in accordance with local clinical practice.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"mobile venous thromboembolism application (mVTEA)","mVTEA will assist in the management of patients during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends venous thromboembolism (VTE)-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication.",[9],[25],{"name":26,"affiliation":27,"role":28},"YU-TAO GUO, Doctor","Sixth Medical Center of Chinese PLA General Hospital","STUDY_CHAIR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"ZHI-GENG JIN, Doctor","CONTACT","8615801402223","lwgjzg@163.com",[36],{"facility":27,"status":18,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":18},"Beijing","Beijing Municipality","100048","China","CN",{"type":43,"coordinates":44},"Point",[45,46],116.39723,39.9075,{"lat":46,"lon":45},{"type":49,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100545448","smart-technology-facilitated-patient-centered-care-for-patients-with-pulmonary-thromboembolism-100545448",false,"NCT06382038","Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism","Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism：A Multicenter, Randomized Controlled Trial","SmaPE","Inclusion Criteria:\n\n* Inpatients aged ≥18 years;\n* （2）PTE confirmed through imaging examinations, meeting at least one of the following criteria: a.Newly diagnosed PTE during the current hospitalization; b. Prior PTE with imaging evidence of residual thrombus.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Previous PTE combined with CTEPH;\n* Mental retardation or a combination of other serious illnesses that make them incapable of living on their own;\n* Inability to use smartphones, computer tablets and other smart devices;\n* Being pregnant or breastfeeding;\n* Have participated in similar trials or are undergoing other clinical trials.","ALL","18 Years",{"count":61,"type":62},2972,"ESTIMATED","INTERVENTIONAL",[65],"NA","Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.\n\nThe objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of pulmonary thromboembolism (PTE) on the long-term outcome of PTE patients, in order to enhance clinical practice and establish a foundation of evidence for managing patients with PTE.",[68,69,70],"Venous Thromboembolism","Pulmonary Thromboembolisms","Digital Health",[68,69,70],"NOT_YET_RECRUITING","2025-05-27",{"date":75,"type":76},"2025-05-31","ACTUAL",{"date":78,"type":62},"2025-10-08",{"date":80,"type":62},"2026-10-31",{"name":5,"class":6},1]